A study of treatment of lung diseases with conditioned medium

JRCT ID: jRCT1051220090

Registered date:14/09/2022

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: lung disease
• Date of first enrollment: 19/08/2022
• Target sample size: 20
• Study type: Observational

Outcome(s)

• Primary Outcome: Changes in KL-6.Changes in High-sensitivity CRP, galectin-3, adiponectin, total antioxidant capacity, grip strength, body composition (weight, muscle mass).
• Secondary Outcome: subjective symptoms, etc.

Key inclusion & exclusion criteria

• Age minimum: >= 18age old
• Age maximum: Not applicable
• Gender: Both

Include criteria

"1. Patients who did not have a satisfactory therapeutic effect with standard treatment by a respiratory physician
2. Patients who do not wish to be treated with the drugs used in standard treatment due to concerns about side effects, etc., and those who have been judged by the doctor that chronic pain treatment with conditioned medium is optimal.

<Inclusion criteria>
Target patients who meet the following criteria.
1. 18 years old and over
2. Have normal consent ability
3. Those who have been diagnosed with diffuse panbronchioles, interstitial lung disease, chronic obstructive pulmonary disease (COPD) or have symptoms of respiratory distress and have lung disease that the doctor has determined to be appropriate treatment. direction
4. Patients who can obtain their free will consent in writing
5. Patients whose doctor have recognized the need for treatment "

Exclude criteria

<Exclusion criteria>
Patient who meet any of the following conditions are excluded
1. Have a history of or suspected of dementia
2. Users of narcotics or stimulants
3. Pregnant, breastfeeding
4. Judged unsuitable by the doctor

Related Information

• Primary Sponsor: Inami Norihito Norihito